Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.
暂无分享,去创建一个
A. Bystritsky | P. Roy-Byrne | G. Asnis | J. Apter | J. Ferguson | D. Munjack | R. Riesenberg | R. Landbloom | M. Kronig | K. Phillips | G. Curtis | D. Robinson | I. J. Du Pont | Peter Roy-Byrne | Robert R. Riesenberg | Gregory M. Asnis | Michael H. Kronig | Jeffrey T. Apter | Alexander Bystritsky | George C. Curtis | James J. Ferguson | Ronald Landbloom | Dennis J. Munjack | Delbert G. Robinson | Kem F. Phillips | Iwona Jeske Du Pont
[1] J. Mendels,et al. A 1 year double‐blind placebo‐controlled fixed dose study of sertraline in the treatment of obsessive‐compulsive disorder , 1995, International clinical psychopharmacology.
[2] M. Liebowitz,et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. , 1995, Archives of general psychiatry.
[3] V. Caillard,et al. Sertraline in the Prevention of Depression , 1992, British Journal of Psychiatry.
[4] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[5] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.
[6] T. Insel,et al. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. , 1983, Archives of general psychiatry.
[7] M. Hamilton,et al. Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.
[8] M. Jenike,et al. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. , 1990, Psychopharmacology bulletin.
[9] P. Wender,et al. Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder. , 1988, Psychopharmacology bulletin.